Heikki Nuutinen
Turku, Finland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Ustekinumab for ulcerative colitis: a nationwide real-life observational cohort study.
Journal: European journal of gastroenterology & hepatology
Published: February 19, 2025
Real-life treatment persistence and treatment outcomes of Finnish patients with inflammatory bowel disease receiving vedolizumab as first-line biological treatment.
Journal: Heliyon
Published: October 17, 2023
A nationwide real-world study on dynamic ustekinumab dosing and concomitant medication use among Crohn's disease patients in Finland.
Journal: Scandinavian journal of gastroenterology
Published: April 06, 2021
Objectively assessed disease activity and drug persistence during ustekinumab treatment in a nationwide real-world Crohn's disease cohort.
Journal: European journal of gastroenterology & hepatology
Published: September 02, 2020
Ustekinumab for Crohn's disease: a nationwide real-life cohort study from Finland (FINUSTE).
Journal: Scandinavian journal of gastroenterology
Published: June 12, 2019
Characterization of inflammatory bowel disease management by vedolizumab and concomitant treatments in real-life clinical practice.
Journal: Biologicals : journal of the International Association of Biological Standardization
Published: October 17, 2018
High treatment persistence rate and significant endoscopic healing among real-life patients treated with vedolizumab - a Finnish Nationwide Inflammatory Bowel Disease Cohort Study (FINVEDO).
Journal: Scandinavian journal of gastroenterology
Published: December 21, 2017
Characterization of hepatic tumors using [11C]metomidate through positron emission tomography: comparison with [11C]acetate.
Journal: EJNMMI research
Published: November 07, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026